Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Flaherty

Showing results (61-70 of 121) with videos related to

Pageof 13
Sort By:
Sexually Transmitted Diseases|September 1, 1992
Underdiagnosis of Chlamydia trachomatis infection. Diagnostic limitations in patients with low-level infectionJ S Lin, W E Jones, L Yan, et al.
Cancer|October 13, 2007
Evaluation of interferon alpha-2B and thalidomide in patients with disseminated malignant melanoma, phase 2, SWOG 0026Laura F Hutchins, James Moon, Joseph I Clark, et al.
Building and Environment|February 3, 2021
Investigation of potential aerosol transmission and infectivity of SARS-CoV-2 through central ventilation systemsLeonard F Pease, Na Wang, Timothy I Salsbury, et al.
Tropical Medicine & International Health : TM & IH|August 3, 2023
Evaluating the prerequisites for adapting a paediatric nighttime telemedicine and medication delivery service to a setting with high malarial burden: A cross-sectional pre-implementation studyKatelyn E Flaherty, Molly B Klarman, Ahmed N Zakariah, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 10, 1998
Phase II trial of recombinant human interleukin-4 in patients with disseminated malignant melanoma: a Southwest Oncology Group studyR P Whitehead, J M Unger, J W Goodwin, et al.
Cancer|June 1, 1990
A phase I-II study of dacarbazine in combination with outpatient interleukin-2 in metastatic malignant melanomaL E Flaherty, B G Redman, G G Chabot, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 21, 2015
Melanin-concentrating hormone is necessary for olanzapine-inhibited locomotor activity in male miceMelissa J S Chee, Nicholas Douris, Avery B Forrow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 13, 2008
Phase III trial comparing concurrent biochemotherapy with cisplatin, vinblastine, dacarbazine, interleukin-2, and interferon alfa-2b with cisplatin, vinblastine, and dacarbazine alone in patients with metastatic malignant melanoma (E3695): a trial coordinated by the Eastern Cooperative Oncology GroupMichael B Atkins, Jessie Hsu, Sandra Lee, et al.
Investigational New Drugs|September 20, 2001
Phase II trial of CI-980 in patients with disseminated malignant melanoma and no prior chemotherapy. A Southwest Oncology Group studyR P Whitehead, J M Unger, L E Flaherty, et al.
Journal of the National Cancer Institute|June 3, 1992
Dacarbazine and outpatient interleukin-2 in treatment of metastatic malignant melanoma: phase II Southwest Oncology Group trialL E Flaherty, P Y Liu, W S Fletcher, et al.
Pageof 13

Showing results (61-70 of 121) with videos related to

Sort By:
Pageof 13
Sexually Transmitted Diseases|September 1, 1992
Underdiagnosis of Chlamydia trachomatis infection. Diagnostic limitations in patients with low-level infectionJ S Lin, W E Jones, L Yan, et al.
Cancer|October 13, 2007
Evaluation of interferon alpha-2B and thalidomide in patients with disseminated malignant melanoma, phase 2, SWOG 0026Laura F Hutchins, James Moon, Joseph I Clark, et al.
Building and Environment|February 3, 2021
Investigation of potential aerosol transmission and infectivity of SARS-CoV-2 through central ventilation systemsLeonard F Pease, Na Wang, Timothy I Salsbury, et al.
Tropical Medicine & International Health : TM & IH|August 3, 2023
Evaluating the prerequisites for adapting a paediatric nighttime telemedicine and medication delivery service to a setting with high malarial burden: A cross-sectional pre-implementation studyKatelyn E Flaherty, Molly B Klarman, Ahmed N Zakariah, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 10, 1998
Phase II trial of recombinant human interleukin-4 in patients with disseminated malignant melanoma: a Southwest Oncology Group studyR P Whitehead, J M Unger, J W Goodwin, et al.
Cancer|June 1, 1990
A phase I-II study of dacarbazine in combination with outpatient interleukin-2 in metastatic malignant melanomaL E Flaherty, B G Redman, G G Chabot, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 21, 2015
Melanin-concentrating hormone is necessary for olanzapine-inhibited locomotor activity in male miceMelissa J S Chee, Nicholas Douris, Avery B Forrow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 13, 2008
Phase III trial comparing concurrent biochemotherapy with cisplatin, vinblastine, dacarbazine, interleukin-2, and interferon alfa-2b with cisplatin, vinblastine, and dacarbazine alone in patients with metastatic malignant melanoma (E3695): a trial coordinated by the Eastern Cooperative Oncology GroupMichael B Atkins, Jessie Hsu, Sandra Lee, et al.
Investigational New Drugs|September 20, 2001
Phase II trial of CI-980 in patients with disseminated malignant melanoma and no prior chemotherapy. A Southwest Oncology Group studyR P Whitehead, J M Unger, L E Flaherty, et al.
Journal of the National Cancer Institute|June 3, 1992
Dacarbazine and outpatient interleukin-2 in treatment of metastatic malignant melanoma: phase II Southwest Oncology Group trialL E Flaherty, P Y Liu, W S Fletcher, et al.
Pageof 13